Post-streptococcal glomerulonephritis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling edema and hypertension. Dietary therapy includes low salt, protein intake, and water restriction. If the streptococcal infection is still present, it should be treated with antibiotics. To control severe hypertension, labetalol is usually used, mild to moderate hypertension, furosemide is used, for rapidly progressive crescentic acute post-streptococcal glomerulonephritis, methylprednisone is preferred.
The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling [[edema]] and [[hypertension]]. Dietary therapy includes low [[salt]], [[protein]] intake, and water restriction. If the [[Streptococcal infections|streptococcal]] infection is still present, it should be treated with [[antibiotics]]. To control severe [[hypertension]], [[labetalol]] is usually used, mild to moderate hypertension, [[furosemide]] is used, for rapidly progressive crescentic acute post-streptococcal glomerulonephritis, [[methylprednisolone]] is preferred.
==Medical therapy==
==Medical therapy==
The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling edema and hypertension
The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling [[edema]] and [[hypertension]]


'''Dietary therapy'''
'''Dietary therapy'''
*Low salt intake
*Low [[salt]] intake
*Low protein intake
*Low [[protein]] intake
*Water restrictions
*[[Water]] restrictions
'''Pharmacotherapy'''
'''Pharmacotherapy'''
*If the streptococcal infection is still present, it should be treated with antibiotics<ref name="pmid11344703">{{cite journal |vauthors=Zoch-Zwierz W, Wasilewska A, Biernacka A, Tomaszewska B, Winiecka W, Wierciński R, Porowski T |title=[The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection] |language=Polish |journal=Wiad. Lek. |volume=54 |issue=1-2 |pages=56–63 |date=2001 |pmid=11344703 |doi= |url=}}</ref>
*If the [[streptococcal infection]] is still present, it should be treated with [[antibiotics]]<ref name="pmid11344703">{{cite journal |vauthors=Zoch-Zwierz W, Wasilewska A, Biernacka A, Tomaszewska B, Winiecka W, Wierciński R, Porowski T |title=[The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection] |language=Polish |journal=Wiad. Lek. |volume=54 |issue=1-2 |pages=56–63 |date=2001 |pmid=11344703 |doi= |url=}}</ref>
*To control severe hypertension, following drugs can be used:
*To control severe hypertension, following drugs can be used:
**Preferred regimen: Labetalol 0.5-2 mg/kg/h IV
**Preferred regimen: [[Labetalol]] 0.5-2 mg/kg/h IV
**If refractory to labetalol then, Preferred regimen: Diazoxide or Nitroprusside 0.5-2 mcg/kg/min IV
**If refractory to labetalol then, Preferred regimen: [[Diazoxide]] or [[Nitroprusside]] 0.5-2 mcg/kg/min IV
*For mild to moderate hypertension:
*For mild to moderate hypertension:
**Preferred regimen: Furosemide 1-3 mg/kg PO q24h
**Preferred regimen: [[Furosemide]] 1-3 mg/kg PO q24h
*For treatment of rapidly progressive crescentic acute post-streptococcal glomerulonephritis, following regimen is used:<ref name="pmid20357732">{{cite journal |vauthors=Zaffanello M, Cataldi L, Franchini M, Fanos V |title=Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children |journal=Med. Sci. Monit. |volume=16 |issue=4 |pages=RA79–84 |date=April 2010 |pmid=20357732 |doi= |url=}}</ref>
*For treatment of rapidly progressive crescentic acute post-streptococcal glomerulonephritis, following regimen is used:<ref name="pmid20357732">{{cite journal |vauthors=Zaffanello M, Cataldi L, Franchini M, Fanos V |title=Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children |journal=Med. Sci. Monit. |volume=16 |issue=4 |pages=RA79–84 |date=April 2010 |pmid=20357732 |doi= |url=}}</ref>
**Preferred regimen: Methylprednisolone
**Preferred regimen: [[Methylprednisolone]]


==References==
==References==

Revision as of 15:54, 12 June 2018

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis medical therapy

CDC on Post-streptococcal glomerulonephritis medical therapy

Post-streptococcal glomerulonephritis medical therapy in the news

Blogs on Post-streptococcal glomerulonephritis medical therapy

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling edema and hypertension. Dietary therapy includes low salt, protein intake, and water restriction. If the streptococcal infection is still present, it should be treated with antibiotics. To control severe hypertension, labetalol is usually used, mild to moderate hypertension, furosemide is used, for rapidly progressive crescentic acute post-streptococcal glomerulonephritis, methylprednisolone is preferred.

Medical therapy

The mainstay of treatment is pharmacotherapy, however dietary therapy is useful for controlling edema and hypertension

Dietary therapy

Pharmacotherapy

  • If the streptococcal infection is still present, it should be treated with antibiotics[1]
  • To control severe hypertension, following drugs can be used:
  • For mild to moderate hypertension:
  • For treatment of rapidly progressive crescentic acute post-streptococcal glomerulonephritis, following regimen is used:[2]

References

  1. Zoch-Zwierz W, Wasilewska A, Biernacka A, Tomaszewska B, Winiecka W, Wierciński R, Porowski T (2001). "[The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection]". Wiad. Lek. (in Polish). 54 (1–2): 56–63. PMID 11344703.
  2. Zaffanello M, Cataldi L, Franchini M, Fanos V (April 2010). "Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children". Med. Sci. Monit. 16 (4): RA79–84. PMID 20357732.

Template:WH Template:WS